Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel D'Incan

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Chest|June 20, 2014
A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosisCatherine Droitcourt, Michel Rybojad, Raphaël Porcher, et al.
Blood|January 17, 2004
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomasFlorent Grange, Tony Petrella, Marie Beylot-Barry, et al.
Clinical & Experimental Metastasis|July 7, 2014
Annexin A1 in primary tumors promotes melanoma disseminationZied Boudhraa, Fabien Rondepierre, Lemlih Ouchchane, et al.
JAMA Dermatology|March 21, 2014
Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in FranceFlorent Grange, Pascal Joly, Coralie Barbe, et al.
The New England Journal of Medicine|August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigusPascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
JAMA Dermatology|February 5, 2025
Optimizing Pemphigus Management With Rituximab and Short-Term Relapse PredictorsVivien Hébert, Sami Hamwi, Emmanuelle Tancrède-Bohin, et al.
American Journal of Clinical Pathology|June 29, 2005
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a reviewTony Petrella, Martine Bagot, Rein Willemze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2013
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trialFlorent Cachin, Elisabeth Miot-Noirault, Brigitte Gillet, et al.
The Journal of Investigative Dermatology|January 30, 2009
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized studyPascal Joly, Jean-Claude Roujeau, Jacques Benichou, et al.
Dermatology (Basel, Switzerland)|November 9, 2022
Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 PatientsAnne Welfringer-Morin, Marion Barroil, Sylvie Fraitag, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Chest|June 20, 2014
A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosisCatherine Droitcourt, Michel Rybojad, Raphaël Porcher, et al.
Blood|January 17, 2004
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomasFlorent Grange, Tony Petrella, Marie Beylot-Barry, et al.
Clinical & Experimental Metastasis|July 7, 2014
Annexin A1 in primary tumors promotes melanoma disseminationZied Boudhraa, Fabien Rondepierre, Lemlih Ouchchane, et al.
JAMA Dermatology|March 21, 2014
Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in FranceFlorent Grange, Pascal Joly, Coralie Barbe, et al.
The New England Journal of Medicine|August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigusPascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
JAMA Dermatology|February 5, 2025
Optimizing Pemphigus Management With Rituximab and Short-Term Relapse PredictorsVivien Hébert, Sami Hamwi, Emmanuelle Tancrède-Bohin, et al.
American Journal of Clinical Pathology|June 29, 2005
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a reviewTony Petrella, Martine Bagot, Rein Willemze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2013
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trialFlorent Cachin, Elisabeth Miot-Noirault, Brigitte Gillet, et al.
The Journal of Investigative Dermatology|January 30, 2009
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized studyPascal Joly, Jean-Claude Roujeau, Jacques Benichou, et al.
Dermatology (Basel, Switzerland)|November 9, 2022
Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 PatientsAnne Welfringer-Morin, Marion Barroil, Sylvie Fraitag, et al.
Pageof 8